A statement from Bosch Australia said the deal was signed by its Manufacturing Solutions division.
It said CSL Behring was a a global biotherapeutics leader that provided therapies for people with rare and serious diseases.
Blood plasma moves in and out of warehouse storage facilities at its Australian manufacturing site in Broadmeadows.
This needed expertise and precision from operators on the line to ensure the product met quality criteria needed to meet highly regulated processing standards.
"With experience in automated robotics solutions, BAMS has the ability to streamline this process, making it more efficient and fully automatic," the company said.
"BAMS will install a material handling and inspection line that will allow more plasma bags to be packed - at up to one per second - while also ensuring temperatures remain stable for transport. The automatic material handling line will expand warehouse capacity."
Bosch Australia president Gavin Smith said: "With a growing portfolio of automation projects for companies in the biotech sector, BAMS is fast becoming the leading supplier of bespoke critical process automation solutions in Australia."